Stay updated on LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Sign up to get notified when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.

Latest updates to the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page
- Check6 days agoChange DetectedThe recruitment status indicates the study is not currently enrolling participants, representing a shift in enrollment activity; a new revision tag v3.6.0 was added and the previous v3.5.5 tag was removed.SummaryDifference0.3%

- Check13 days agoChange DetectedA new latest revision entry v3.5.5 appears in the history, indicating the record has been updated. The previous revision v3.5.4 is superseded by the new version.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedA new revision label v3.5.4 was added to the history and the previous v3.5.3 was removed. This indicates an update to the page's revision metadata.SummaryDifference0.1%

- Check49 days agoChange DetectedA new revision entry, v3.5.3, was added to the record history, replacing the previous v3.5.2. This indicates an updated build/version of the page in the history.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded revision v3.5.2 to the history and removed revision v3.5.0.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision history updated: added version v3.5.0 and removed version v3.4.3.SummaryDifference0.1%

Stay in the know with updates to LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM
Enter your email address, and we'll notify you when there's something new on the LEGEND Clinical Trial: Lanifibranor and EmpaGliflozin in NASH with T2DM page.